BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10901696)

  • 1. Oxidative cleavage of the octyl side chain of 1-(3,4-dichlorobenzyl)-5-octylbiguanide (OPB-2045) in rat and dog liver preparations.
    Umehara K; Kudo S; Hirao Y; Morita S; Uchida M; Odomi M; Miyamoto G
    Drug Metab Dispos; 2000 Aug; 28(8):887-94. PubMed ID: 10901696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative one-carbon cleavage of the octyl side chain of olanexidine, a novel antimicrobial agent, in dog liver microsomes.
    Umehara K; Shimokawa Y; Koga T; Ohtani T; Miyamoto G
    Xenobiotica; 2004 Jan; 34(1):61-71. PubMed ID: 14742137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of the oxidative cleavage of the octyl side chain of olanexidine, a novel antimicrobial agent, in dog liver microsomes.
    Umehara K; Kudo S; Hirao Y; Morita S; Ohtani T; Uchida M; Miyamoto G
    Drug Metab Dispos; 2000 Dec; 28(12):1417-24. PubMed ID: 11095578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro metabolism of ethoxidine by human CYP1A1 and rat microsomes: identification of metabolites by high-performance liquid chromatography combined with electrospray tandem mass spectrometry and accurate mass measurements by time-of-flight mass spectrometry.
    Deroussent A; Ré M; Hoellinger H; Vanquelef E; Duval O; Sonnier M; Cresteil T
    Rapid Commun Mass Spectrom; 2004; 18(4):474-82. PubMed ID: 14966856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of sanguinarine in human and in rat: characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry.
    Deroussent A; Ré M; Hoellinger H; Cresteil T
    J Pharm Biomed Anal; 2010 Jul; 52(3):391-7. PubMed ID: 19804952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification.
    Kumar GN; Jayanti V; Lee RD; Whittern DN; Uchic J; Thomas S; Johnson P; Grabowski B; Sham H; Betebenner D; Kempf DJ; Denissen JF
    Drug Metab Dispos; 1999 Jan; 27(1):86-91. PubMed ID: 9884314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I metabolism of ganstigmine. Rat, dog, monkey and human liver microsomal extracts investigated by liquid chromatography electrospray tandem mass spectrometry.
    Catinella S; Pelizzi N; Puccini P; Marchetti S; Zanol M; Acerbi D; Ventura P
    J Mass Spectrom; 2001 Dec; 36(12):1287-93. PubMed ID: 11754120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
    Remmel RP; Crews BC; Kozak KR; Kalgutkar AS; Marnett LJ
    Drug Metab Dispos; 2004 Jan; 32(1):113-22. PubMed ID: 14709628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
    Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
    Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
    Lang D; Freudenberger C; Weinz C
    Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism studies of the anti-tumor agent maytansine and its analog ansamitocin P-3 using liquid chromatography/tandem mass spectrometry.
    Liu Z; Floss HG; Cassady JM; Chan KK
    J Mass Spectrom; 2005 Mar; 40(3):389-99. PubMed ID: 15674857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new pathway for the oxidative metabolism of chloramphenicol by rat liver microsomes.
    Morris PL; Burke TR; George JW; Pohl LR
    Drug Metab Dispos; 1982; 10(5):439-45. PubMed ID: 6128189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro comparison of thienorphine metabolism in liver microsomes of human, Beagle dog and rat].
    Deng JT; Zhuang XM; Li H
    Yao Xue Xue Bao; 2010 Jan; 45(1):98-103. PubMed ID: 21351457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species differences in the elimination of a peroxisome proliferator-activated receptor agonist highlighted by oxidative metabolism of its acyl glucuronide.
    Kochansky CJ; Xia YQ; Wang S; Cato B; Creighton M; Vincent SH; Franklin RB; Reed JR
    Drug Metab Dispos; 2005 Dec; 33(12):1894-904. PubMed ID: 16183782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of a 14C/3H-labeled GABAA receptor partial agonist in rat, dog and human liver microsomes: evaluation of a dual-radiolabel strategy.
    Shaffer CL; Langer CS
    J Pharm Biomed Anal; 2007 Mar; 43(4):1195-205. PubMed ID: 17150324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of cyadox in rat, chicken and pig liver microsomes and identification of metabolites by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry.
    Liu Z; Huang L; Dai M; Chen D; Tao Y; Wang Y; Yuan Z
    Rapid Commun Mass Spectrom; 2009 Jul; 23(13):2026-34. PubMed ID: 19504544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon-carbon Bond Cleavage Catalyzed by Human Cytochrome P450 Enzymes: α-ketol as the Key Intermediate Metabolite in Sequential Metabolism of Olanexidine.
    Hu Y; Xiao Y; Rao Z; Kumar V; Liu H; Lu C
    Drug Metab Lett; 2021; 14(1):41-53. PubMed ID: 31763971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
    Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
    Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.